The endostatin (E) and CTX (C)-treated samples exhibited almost similar expression levels for NOTCH-3, JAG-1, and DLL-4 that confirms the additive effect of the combination therapy against tumor angiogenesis. This evidence concerns the gene NOTCH3 and neoplasm.